Skip to main content
. 2013 Mar;131(3):e789–e796. doi: 10.1542/peds.2012-2072

TABLE 2.

Patient Characteristics

Control (n = 786) Intervention (n = 825) P
Age, y 7.07 (5.04) 6.88 (4.70) .4318
Gender
 Female 379 (48.2) 416 (50.4) .3962
 Male 407 (51.8) 409 (49.6)
Mother deceased
 No 608 (77.5) 650 (78.9) .7853
 Yes 173 (22.0) 170 (20.6)
 Unknown 4 (0.5) 4 (0.5)
Father deceased
 No 584 (74.4) 615 (74.6) .4826
 Yes 185 (23.6) 185 (22.5)
 Unknown 16 (2.0) 24 (2.9)
HIV status (at enrollment)
 Exposed 113 (14.5) 117 (14.2) .0841
 Negative 99 (12.7) 139 (16.9)
 Positive 570 (72.9) 569 (69.0)
ARTa
 No 293 (42.7) 296 (43.2) .8701
 Yes 394 (57.4) 390 (56.9)
WHO stageb
 1 113 (20.0) 111 (19.7) .7200
 2 114 (20.1) 129 (22.9)
 3 295 (52.1) 280 (49.7)
 4 44 (7.8) 43 (7.6)

Values are frequency (percent) for categorical variables and means (SDs) for continuous variables; P values are from χ2 tests for categorical variables and Student t test for continuous variables. ARV, antiretroviral; WHO, World Health Organization.

a

HIV-negative children were excluded in this analysis.

b

HIV-negative and HIV-exposed children were excluded from this analysis.